The temporary restraining order would prevent the enforcement of these regulations while the lawsuit is being litigated.

Fun fact! A cup of butternut squash contains more than 100% of the daily value of vitamin A.

Researchers used standardized questionnaires and an Oura ring to measure sleep quality and functioning after waking up.

NutraShure will be at SupplySide West 2024 with two new ingredients to show attendees.

The two companies have been expanding their operations and technology to meet the needs of the global nutraceutical industry.

How the sports nutrition category is changing and what that means for manufacturers.

The Everwell Health Company, Nutrition21, will present a variety of product options at SupplySide West 2024.

The ingredients developer will also be highlighting new clinical science and delivery system options.

The bill would amend the definition of hemp to raise the threshold of delta-9 THC to 1% from 0.3%.

In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.

A recent press release disclosed that Health Canada approved a functional claim authorization for SynbÆctive Femme, a patented probiotic formula used in women’s health.

The >Your< Back Pain Capsules, combined with physical therapy, provided more pain relief and mobility than physical therapy alone.

Both a higher and lower dose of the extract was shown to reduce appetite and cravings.

Fun fact! Raw apples eaten before and after garlic-rich foods may be an effective remedy for garlic breath.

Helaina raised $45 million in Series B funding with plans to fasten the commercialization of human bioactive proteins.